MED
MEDIFAST INC
NYSE · Consumer Cyclical · Personal Products & Services · US
$11.77
−1.59%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$11.93
From 52W high−19.22%
Volume398979.00
Market cap$131.60M
P/E (TTM)—
P/S (TTM)0.4x
Div yield—
Key dataSep 18, 2026
Open
$11.93
From 52W high
−19.22%
Volume
398979.00
Market cap
$131.60M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
3.0x
P/E (TTM)
—
RSI (14)
50.5
MomentumView details →
1D Return
−1.59%
YTD Return
+11.70%
SummaryUpdated Jun 1, 2026
Medifast, Inc. (NASDAQ:MED) is a weight management and nutritional products company founded in 1980 and headquartered in Baltimore, Maryland. The company went public in 1993 and has evolved from a traditional diet company into a coach-supported weight loss platform. Medifast primarily operates through its OPTAVIA brand, which uses a network of independent health coaches to distribute meal replacement products and provide personalized weight management support. The company has faced significant challenges in recent years due to the emergence of GLP-1 weight loss medications like Ozempic and Wegovy, forcing a strategic pivot to adapt to the changing weight loss landscape.
Similar companies
Latest newsMore news →
Medifast, Inc. launched the Medifast Metabolic Health Institute to advance metabolic health through research and evidence-based education, consolidating its clinical research and scientific expertise under one body.24d agoMedifast reported its financial results for the second quarter ended June 30, 2026, including revenue of $76.4 million, a net loss of $3.1 million, and cash and investments of $169.8 million.48d ago